Restricted accessResearch articleFirst published online 2025
Development of a technology-enhanced patient-reported outcome evaluation system for inflammatory bowel disease: A multidimensional approach to assessing survival quality
Inflammatory Bowel Disease (IBD) significantly affects patients’ long-term health and survival quality. Accurate and technology-driven assessment tools are essential for monitoring disease impact and optimizing individualized treatment strategies.
Objective
To develop a standardized and technology-enhanced evaluation system for IBD based on patient-reported outcomes (IBDPRO), enabling a comprehensive and dynamic assessment of patients’ survival quality.
Methods
A multidimensional evaluation system was constructed using the three-dimensional quality structure model. The framework incorporated expert consensus through the Delphi method, semi-structured interviews, and analytic hierarchy process (AHP) for weight assignment. A digital platform based on the REDCap system was used for data collection and patient follow-up. Statistical correlations were analyzed between survival quality scores and disease activity indices (PMS and HBI), as well as subjective self-assessments.
Results
High expert authority coefficients (0.926, 0.931) and significant agreement levels (Kendall's W = 0.226, 0.239, P < 0.01) were achieved. survival quality was strongly negatively correlated with disease activity (Spearman's r = -0.76, P < 0.001) and positively correlated with patients’ self-perceived condition changes (r = 0.79, P < 0.001). The system demonstrated reliability, validity, and responsiveness across multiple dimensions.
Conclusions
The IBDPRO system provides a scientifically rigorous and technologically integrated method for evaluating the survival quality in IBD patients. This approach facilitates data-driven clinical decision-making and supports a transition toward personalized, patient-centered healthcare.
SinghAGuptaYKDhaliwalAS, et al.Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD. Intest Res2023; 21: 375–384.
2.
MassiminoLLamparelliLAHoushyarY, et al.The inflammatory bowel disease transcriptome and metatranscriptome meta-analysis (IBD TaMMA) framework. Nat Comput Sci2021; 1: 511–515.
3.
EvansSOliveLDoberM, et al.Acceptance commitment therapy (ACT) for psychological distress associated with inflammatory bowel disease (IBD): protocol for a feasibility trial of the ACTforIBD programme. Bmj Open2022; 12: e060272.
4.
GrantRKBrindleWMArnottI. The value of a dedicated IBD flare clinic to effectively manage exacerbations of inflammatory bowel disease: the Edinburgh IBD unit. Inflamm Bowel Dis2023; 29: 665–668.
5.
MearinFSansMBalboaA.Relevance and needs of irritable bowel syndrome (IBS): comparison with inflammatory bowel disease (IBD). (Please, if you are not interested in IBS, read it.).Gastroent Hepat-Barc2022; 45: 789–798.
6.
BarnesAAndrewsJMMukherjeeS, et al.Insomnia is common in inflammatory bowel disease (IBD) and is associated with mental health conditions as well as IBD activity. Intest Res2024; 22: 104–114.
7.
SchuchardJCarleACKappelmanMD, et al.Interpreting patient-reported outcome scores: pediatric inflammatory bowel disease as a use case. Acad Pediatr2022; 22: 1520–1528.
8.
BrennerEJLinLBahnsonKM, et al.Computerized-adaptive testing versus short forms for pediatric inflammatory bowel disease patient-reported outcome assessment. J Clin Transl Sci2023; 7: e109.
9.
CrossRKCheeversNRustgiA, et al.Randomized, controlled trial of home telemanagement in patients with ulcerative colitis (UC HAT). Inflamm Bowel Dis2012; 18: 1018–1025.
10.
BennebroekEFHoeksCCNieuwkerkPT, et al.Development of the patient Harvey Bradshaw index and a comparison with a clinician-based Harvey Bradshaw index assessment of Crohn's disease activity. J Clin Gastroenterol2013; 47: 850–856.
11.
de SilvaSSteedHAllenPB, et al.Assessing disease control in inflammatory bowel disease: a real world cross-sectional study in the UK (PODCAST-IBD). Curr Med Res Opin2024; 40: 1847–1854.
12.
YanXQiaoYTongJ, et al.Assessment of patient-centered outcomes (PROs) in inflammatory bowel disease (IBD): a multicenter survey preceding a cross-disciplinary (functional) consensus. Health Qual Life Out2020; 18: 241.
13.
MoonkaewPPolsookR. Validity and reliability of a Thai version of the body image scale among patients with post-coronary artery bypass graft. Belitung Nurs J2023; 9: 280–286.
14.
WangMLuXLiuM. The mediating effect of psychological resilience on the level of mindfulness and general well-being in patients with inflammatory bowel disease. Ann Palliat Med2021; 10: 9215–9222.
15.
VarbobitisIKokkotisGGizisM, et al.The IBD-F patient self-assessment scale accurately depicts the level of fatigue and predicts a negative effect on the quality of life of patients with IBD in clinical remission. Inflamm Bowel Dis2021; 27: 826–835.
16.
de JongMETaalEThomasP, et al.Cross-cultural translation and validation of the IBD-control questionnaire in The Netherlands: a patient-reported outcome measure in inflammatory bowel disease. Scand J Gastroentero2021; 56: 155–161.
17.
Calvino-SuarezCFerreiro-IglesiasRBaston-ReyI,et al.Role of quality of life as endpoint for inflammatory bowel disease treatment. Int J Env Res Pub He2021; 18: 7159.
18.
BarnesELKappelmanMDLongMD, et al.A novel patient-reported outcome-based evaluation (PROBE) of quality of life in patients with inflammatory bowel disease. Am J Gastroenterol2019; 114: 640–647.
19.
KaniHTErgencIArikanH, et al.Validation and reliability of the turkish version of the inflammatory bowel disease questionnaire for ulcerative colitis and crohn's disease. Turk J Gastroenterol2020; 31: 566–572.
20.
CalvetXSaldanaRCarpioD, et al.Improving quality of care in inflammatory bowel disease through Patients’ eyes: IQCARO project. Inflamm Bowel Dis2020; 26: 782–791.
21.
GuagnanoMTD'AngeloCCanigliaD, et al.Improvement of inflammation and pain after three Months’ exclusion diet in rheumatoid arthritis patients. Nutrients2021; 13: 3535.
22.
Tsang-A-SjoeMBultinkIHeslingaM, et al.The relationship between remission and health-related quality of life in a cohort of SLE patients. Rheumatology2019; 58: 628–635.
23.
IbnYYAmineBLaatirisA, et al.Health-related quality of life in Moroccan patients with ankylosing spondylitis. Clin Rheumatol2011; 30: 673–677.
24.
GazineoDGodinoLBuiV, et al.Health-related quality of life in outpatients with chronic liver disease: a cross-sectional study. Bmc Gastroenterol2021; 21: 318.
25.
AsadollahzadehEEbadiZOwjiM, et al.Exploring the relationship between disability status, depression, and quality of life in individuals with multiple sclerosis. Mult Scler Relat Dis2024; 87: 105629.
26.
DaCRESDaSCSYazbekMA, et al.Validation and clinical interpretability of PsAID - psoriatic arthritis impact of disease. Adv Rheumatol2020; 60: 49.
27.
KrasseltMBaerwaldC. Sex, symptom severity, and quality of life in rheumatology. Clin Rev Allerg Immu2019; 56: 346–361.
28.
Posada-LopezABoteroJEDuque-CastanoJD, et al.Oral health-related quality of life in a group of patients with rheumatoid arthritis. Dent Med Probl2023; 60: 109–119.
29.
CotterRAHousseinFAReinertRK, et al.Patient perspectives on international multidisciplinary consensus criteria for chronic rhinosinusitis disease control. Laryngoscope Invest2024; 9: e70005.
30.
WangMSunYZhangM, et al.Effects of high-quality nursing care on quality of life, survival, and recurrence in patients with advanced nonsmall cell lung cancer. Medicine (Baltimore).2022; 101: e30569.
31.
TrejoMJBellMLDhillonHM,et al.Baseline quality of life is associated with survival among people with advanced lung cancer. J Psychosoc Oncol2020; 38: 635–641.
32.
ScholtenWSeldenrijkAHoogendoornA, et al.Baseline severity as a moderator of the waiting list-controlled association of cognitive behavioral therapy with symptom change in social anxiety disorder: a systematic review and individual patient data meta-analysis. Jama Psychiat2023; 80: 822–831.
33.
PriebeSMcCabeRJunghanU, et al.Association between symptoms and quality of life in patients with schizophrenia: a pooled analysis of changes over time. Schizophr Res2011; 133: 17–21.
34.
GurbuzIZAkinS. Relationship between quality of life, self-efficacy and social support in patients with multiple sclerosis. Int J Palliat Nurs2023; 29: 598–612.
35.
SantacroceGZammarchiINardoneOM, et al.Rediscovering histology - the application of artificial intelligence in inflammatory bowel disease histologic assessment. Ther Adv Gastroenter2025; 18: 1128508501.
36.
PaulidesEBoukemaIvan der WoudeCJ,et al.The effect of psychotherapy on quality of life in IBD patients: a systematic review. Inflamm Bowel Dis2021; 27: 711–724.
37.
ClickBCrossRKRegueiroM,et al.The IBD clinic of tomorrow: holistic, patient-centric, and value-based care. Clin Gastroenterol H2025; 23: 419–427.
